Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1997-1-23
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0965-2140
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
91
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1388-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8854377-Administration, Cutaneous,
pubmed-meshheading:8854377-Brain,
pubmed-meshheading:8854377-Dopamine,
pubmed-meshheading:8854377-Humans,
pubmed-meshheading:8854377-Monoamine Oxidase,
pubmed-meshheading:8854377-Nicotine,
pubmed-meshheading:8854377-Psychoses, Substance-Induced,
pubmed-meshheading:8854377-Smoking Cessation
|
pubmed:year |
1996
|
pubmed:articleTitle |
A role for dopamine in nicotine psychosis?
|
pubmed:publicationType |
Letter
|